1. Home
  2. ANL vs BORR Comparison

ANL vs BORR Comparison

Compare ANL & BORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

N/A

Current Price

$10.80

Market Cap

998.8M

Sector

N/A

ML Signal

N/A

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

N/A

Current Price

$3.43

Market Cap

995.8M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
ANL
BORR
Founded
2004
2016
Country
Singapore
Bermuda
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
998.8M
995.8M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
ANL
BORR
Price
$10.80
$3.43
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
★ $29.50
$4.88
AVG Volume (30 Days)
268.1K
★ 9.1M
Earning Date
08-14-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$243.83
N/A
Revenue Next Year
N/A
$19.44
P/E Ratio
★ N/A
$20.64
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$2.89
52 Week High
$17.25
$6.66

Technical Indicators

Market Signals
Indicator
ANL
BORR
Relative Strength Index (RSI) 46.74 40.33
Support Level $8.95 N/A
Resistance Level $11.90 $4.64
Average True Range (ATR) 0.99 0.23
MACD 0.25 -0.03
Stochastic Oscillator 72.55 24.71

Price Performance

Historical Comparison
ANL
BORR

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

Share on Social Networks: